NCT01293357View on ClinicalTrials.gov

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Healthy
Interventions
DRUG

LEO 90105

Ointment

Trial Locations (1)

812-0025

Hakata Clinic LTA Clinical Pharmacology Center, Fukuoka

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

LEO Pharma

INDUSTRY